Research facilities and biotechnology firms are striving to develop effective vaccines or drugs against the novel coronavirus, but people must still practice the “new disease prevention lifestyle” to protect themselves, the Central Epidemic Command Center (CECC) reminded the public yesterday as it reported no new cases of COVID-19.
“As there have been no domestic cases reported for many consecutive days [52], local communities in Taiwan are relatively safe, but we still need to rely on the development of vaccines and drugs to effectively control the overall situation,” Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said at the center’s daily news conference in Taipei.
Eight COVID-19 patients remain hospitalized, but 428 people have recovered and been released from isolation, he said.
Photo: Lin Hui-chin, Taipei Times
While disease prevention regulations are to be eased on Sunday, that does not mean doing away with all protective measures before an effective vaccine or medication is developed, Chen said.
The main principles include keeping proper social distance or wearing a mask, frequently washing hands and checking your temperature, and enforcing name registration to keep contact records in places where it is needed, he said.
The center encourages people to visit restaurants and businesses that implement disease prevention measures, he added.
National Health Research Institute (NHRI) president Liang Kung-yee (梁賡義) told the news conference that more than 100 teams around the world are trying to develop a vaccine, and so far 10 candidates have progressed to the clinical trial phases: three types of nucleic acid vaccines, two types of recombinant vaccines, four types of inactivated vaccines and one type of subunit vaccine.
The institute is cooperating with three local biotechnology firms on the development of four vaccines, and Academia Sinica is working with two others on two more vaccines, Liang said.
A subunit vaccine is expected to go into clinical trial phases this autumn at the earliest, he said.
As for the development of antiviral drugs, while the Food and Drug Administration (FDA) last week gave rapid conditional approval to remdesivir, and hydroxychloroquine, a drug used to treat malaria and other diseases, is going through clinical trial, potential drugs are being developed in Taiwan, he said.
The NHRI discovered a wide-effect coronavirus antibody during the 2003 SARS outbreak and is using it to develop a potential treatment for COVID-19, Academia Sinica is developing possible treatments using several protease inhibitors of COVID-19 that it has identified, and a joint research team from the NHRI, the National Defense Medical Center and Chang Gung University is developing a monoclonal antibody drug, Liang said.
The FDA has also approved four — out of 13 applications — to manufacture COVID-19 testing kits and approved 19 — out of 75 — applications to import testing kits.
Chang Shan-chwen (張上淳), convener of the CECC advisory specialist panel, on Tuesday said that the prevalence of COVID-19 is expected to be less than 1 percent, or possibly under 0.1 percent, but the margin of error of rapid test kits means that those test results could be seriously misleading, with many false-negative or false-positive cases.
His comments came one day after the National Taiwan University College of Public Health and Changhua County Public Health Bureau began conducting COVID-19 antibody tests on about 10,000 county residents.
Such research can be conducted for academic purposes and must be carefully reviewed, although the results would likely have very limited impact on the government’s disease prevention or control policies, he added.
Taiwan is to receive the first batch of Lockheed Martin F-16 Block 70 jets from the US late this month, a defense official said yesterday, after a year-long delay due to a logjam in US arms deliveries. Completing the NT$247.2 billion (US$7.69 billion) arms deal for 66 jets would make Taiwan the third nation in the world to receive factory-fresh advanced fighter jets of the same make and model, following Bahrain and Slovakia, the official said on condition of anonymity. F-16 Block 70/72 are newly manufactured F-16 jets built by Lockheed Martin to the standards of the F-16V upgrade package. Republic of China
Taiwan-Japan Travel Passes are available for use on public transit networks in the two countries, Taoyuan Metro Corp said yesterday, adding that discounts of up to 7 percent are available. Taoyuan Metro, the Taipei MRT and Japan’s Keisei Electric Railway teamed up to develop the pass. Taoyuan Metro operates the Taiwan Taoyuan International Airport MRT Line, while Keisei Electric Railway offers express services between Tokyo’s Narita Airport, and the Keisei Ueno and Nippori stations in the Japanese capital, as well as between Narita and Haneda airports. The basic package comprises one one-way ticket on the Taoyuan MRT Line and one Skyliner ticket on
A new tropical storm formed late yesterday near Guam and is to approach closest to Taiwan on Thursday, the Central Weather Administration (CWA) said. Tropical Storm Pulasan became the 14th named storm of the year at 9:25pm yesterday, the agency said. As of 8am today, it was near Guam traveling northwest at 21kph, it said. The storm’s structure is relatively loose and conditions for strengthening are limited, WeatherRisk analyst Wu Sheng-yu (吳聖宇) said on Facebook. Its path is likely to be similar to Typhoon Bebinca, which passed north of Taiwan over Japan’s Ryukyu Islands and made landfall in Shanghai this morning, he said. However, it
Starlux Airlines, Taiwan’s newest international carrier, has announced it would apply to join the Oneworld global airline alliance before the end of next year. In an investor conference on Monday, Starlux Airlines chief executive officer Glenn Chai (翟健華) said joining the alliance would help it access Taiwan. Chai said that if accepted, Starlux would work with other airlines in the alliance on flight schedules, passenger transits and frequent flyer programs. The Oneworld alliance has 13 members, including American Airlines, British Airways, Cathay Pacific and Qantas, and serves more than 900 destinations in 170 territories. Joining Oneworld would also help boost